Page last updated: 2024-09-03

reboxetine and Nerve Degeneration

reboxetine has been researched along with Nerve Degeneration in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Caso, JR; García-Bueno, B; González-Prieto, M; Gutiérrez, IL; Leza, JC; Madrigal, JLM	1

Other Studies

1 other study(ies) available for reboxetine and Nerve Degeneration

Article	Year
Reboxetine Treatment Reduces Neuroinflammation and Neurodegeneration in the 5xFAD Mouse Model of Alzheimer's Disease: Role of CCL2. Molecular neurobiology, 2019, Volume: 56, Issue:12 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Axons; Biomarkers; Chemokine CCL2; Cyclooxygenase 2; Disease Models, Animal; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Inflammation; Memory Disorders; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Nerve Degeneration; Reboxetine	2019

Article

Year

Reboxetine Treatment Reduces Neuroinflammation and Neurodegeneration in the 5xFAD Mouse Model of Alzheimer's Disease: Role of CCL2.

Molecular neurobiology, 2019, Volume: 56, Issue:12

Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Axons; Biomarkers; Chemokine CCL2; Cyclooxygenase 2; Disease Models, Animal; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Inflammation; Memory Disorders; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Nerve Degeneration; Reboxetine

2019